Early research (Phase 1)Not Yet RecruitingNCT07408908
What this trial is testing
Safety, Tolerability, and Pharmacokinetic/Pharmacodynamic (PK/PD) Profile of ACT100 in Healthy Participants..
Who this might be right for
Systemic Lupus ErythematosusCutaneous Lupus Erythematosus
Xiamen Amoytop Biotech Co., Ltd. 48